The Onco'Zine Brief-logo

The Onco'Zine Brief

News & Politics Podcasts

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland, Ph.D., covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland, Ph.D., covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.

Location:

United States

Description:

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland, Ph.D., covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.

Twitter:

@oncozine

Language:

English

Contact:

480 626 7218

Episodes

A Bold Approach in the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma

2/3/2021
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talk with Ajay Nooka, MD, MPH, FACP, Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine in Atlanta, and Suzanne Trudel, MSc, MD, Associate Professor in the Department of Medicine at the University of Toronto and an Attending Physician at Princess Margaret Cancer Centre. Hofland, Nooka, and Trudel talk about a recently approved drug indicated for the treatment of adult...

Duration:00:49:44

Developing Transformative Therapies for Patients with Diffuse Large B-cell Lymphoma

2/3/2021
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Malte Peters, MD, Chief Research and Development Officer at MorphoSys, and Peter Langmuir, MD., Vice President, Oncology Drug Development at Incyte. In our program today, which was originally recorded in August 2020, Hofland, Peters, and Langmuir also talk about the companies and the transformative therapies they have developed for patients diagnosed with Diffuse Large B-cell Lymphoma that has come back or that did not...

Duration:00:43:48

Richard Schilsky, M.D. - A Deep Passion for Cancer Medicine

12/16/2020
In this episode of The Onco’Zine Brief Peter Hofland talks with Richard Schilsky, M.D. Dr. Schilsky, the Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology (ASCO), is an oncologist who specializes in new drug development and treatment of gastrointestinal cancers. His impressive experience and many accomplishments in both clinical medicine and clinical research, reflect his deep passion for cancer medicine. As a highly respected leader in the...

Duration:00:48:54

Pascal Touchon: A Mission to Transform the Lives of Patients with Serious Medical Conditions

12/1/2020
In this episode of The Onco’Zine Brief Peter Hofland talks with Pascal Touchon, President, Chief Executive Officer, and member of the Board of Directors Atara Biotherapeutics. With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon has committed his career to transform the lives of patients with serious medical conditions. Before joining Atara Biotherapeutics Dr. Touchon was Global Head, Cell & Gene and member of the Oncology Executive Committee at...

Duration:00:49:00

Accelerate the Development of Precision Medicine Diagnostics

11/17/2020
In this edition of The Onco’Zine Brief Peter Hofland talks with Peter Keeling about Personalized Medicine, diagnostic testing, and the effect of Covid-19 on cancer and cancer diagnostics. Hofland and Keeling also talk about the world’s first Diagnostic Network for Precision Medicine. Peter Keeling is the chief executive officer and Founder of Diaceutics. Since its founding, the company has built the world’s largest repository of diagnostic testing data with a growing network of 2,500...

Duration:00:48:04

The Burden of Chemotherapy-induced Myelosuppression

10/27/2020
In this episode of The Onco’Zine Brief Peter Hofland Ph.D., talks with Raj Malik M.D. and Robert Epstein M.D. Malik is Chief Medical Officer and Senior Vice President, R&D, at G1 Therapeutics. He leads the company’s clinical development, medical affairs, regulatory affairs, biometrics, translational medicine and preclinical teams. Epstein is an epidemiologist with extensive expertise in pharmaco-economics and health outcomes research. He served in academia and public health prior to joining...

Duration:00:46:42

Antibody-dye Conjugates – A Targeted Light Activated Anti-Cancer Treatment

10/24/2020
In this episode of The Onco’Zine Brief Peter Hofland talks with Peggy Berry, Vice president of Global Regulatory Affairs at Rakuten Medical.* Rakuten Medical is developing a technology platform called Illuminox™ which is based on a cancer therapy called Near Infrared Photoimmunotherapy. This technology was originally developed by Hisataka Kobayashi, M.D., Ph.D. and his team at the National Cancer Institute (NCI) in the United States. [1] Rakuten Medical’s first investigational drug, based...

Duration:00:49:10

C3 – Looking for Ideas Beyond Medicine to Change Cancer Care

9/22/2020
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Anthony Yanni, M.D., Senior Vice President, patient-centricity at Astellas. In this role, Yanni is responsible for leading the development and execution of Astellas’ global patient-centricity strategy. To understand patient centricity, consider the fact that 10 years ago, patient-centricity wasn’t even a concept – In most cases, drugs were developed if scientists could achieve innovation, without considering if companies...

Duration:00:47:42

A Non-Invasive Blood Test Designed to Advance Infectious Disease Diagnostics

8/25/2020
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D., talks with Tim Blauwkamp, Ph.D., Chief Scientific Officer and co-founder of Karius. Karius, based in Redwood City, CA, has developed a non-invasive liquid biopsy, a blood test, called the Karius Test®. The test is based on next-generation sequencing of microbial cell-free DNA and can rapidly detect pathogens causing serious infections, including those diseases that are difficult to diagnose through conventional methods. The test...

Duration:00:49:02

Diagnosed with a Rare Cancer During the COVID-19 Pandemic? What Now?

8/17/2020
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talks with Vince McRuiz and Margo Shoup, MD, FACS. Margo Shoup is a nationally recognized surgical oncologist who specializes in gastrointestinal cancers and sarcomas. She is also the senior vice president, and system chair of the Nuvance Health Cancer Institute, where she provides strategic and clinical leadership for all aspects of Nuvance Health’s cancer services. Vince McRuiz is a patient of Dr. Shoup. In March 2020 just...

Duration:00:47:40

Transforming Cell Therapy Manufacturing by “Squeezing” Cells: An Interview with Armon Sharei

7/12/2020
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Armon Sharei, Ph.D. Chief Executive Officer of SQZ Biotech, about the development and manufacturing of cell therapies. Traditionally, the foundation of cancer treatment included surgery, chemotherapy, and radiation therapy. But over the last few decades, targeted therapies —drugs that specifically target molecular changes seen primarily on cancer cells—have become a standard treatment for many cancers. In addition,...

Duration:00:43:59

ASCO 2020: New Developments in the Treatment of Hard to Treat Cancers

7/11/2020
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Christian Massacesi, MD, Senior Vice President, Head of Late Development Oncology R&D at AstraZeneca and with Jeffrey Skolnik, MD, Vice President, Clinical Development at Inovio Pharmaceuticals about new data and exciting developments both companies are presenting during the 2020 virtual annual meeting of the American Society of Clinical Oncology – ASCO. This year, amidst the SAR-CoV-2 or coronavirus pandemic, the ASCO...

Duration:00:46:41

Advancing CAR T-cell Therapy in Difficult to Treat Cancers: An Interview with Precigen’s Helen Sabzevari

7/3/2020
In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a biopharmaceutical company dedicated to the discovery and clinical-stage development of the next generation of gene and cell therapies using precision technology. The company is developing novel therapeutic agents that are designed to target the most urgent and difficult diseases in immuno-oncology, autoimmune disorders, and infectious diseases. During the second part...

Duration:00:47:38

Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC

6/16/2020
In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks following the interview, the U.S. Food and Drug Administration (FDA) approved sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC)...

Duration:00:46:57

Finding Community After a Cancer Diagnosis: A Conversation with Terri Conneran

6/3/2020
Struggling in the heat and humidity of the summer of 2016, Terri Conneran believed that her asthma was uncontrolled. In August that year, her physician assistant prescribed her a preventive inhaler. That autumn brought the excuse of allergies, plus time for the new inhaler to take effect. By Christmas 2016, nasal congestion, and a heavy feeling chest with shortness of breath it was time to again see her doctor. Hearing fluid in her lungs, an x-ray showed a mass with fluid. Pneumonia was...

Duration:00:47:18

Susan Rafte: A 25+ Year Survivor of Metastatic Breast Cancer and Patient Advocate

12/24/2019
In this episode The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with Susan Rafte, a 25+ year survivor of metastatic breast cancer and patient advocate. In 1994, eight and a half months after birth to her daughter Marika, Susan Rafte, only 30 years old, was diagnosed with stage III ductal carcinoma. While she was pregnant with her daughter, she first felt a lump in her breast....

Duration:00:49:22

Candid Conversations on Mets, Sex, and Side Effects: a Panel Discussion With Breast Cancer Oncologists, Women’s Health Experts and Patients

12/24/2019
In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 - 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life hrQoL issues including sexual intimacy, bone health and joint pain. In this roundtable, panelists will also discuss liquid biomarkers for disease progression in the metastatic setting. The expert...

Duration:00:51:28

Catherine Ivy: A Tireless Advocate for Brain Cancer Patients

11/23/2019
In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in North America, Europe, and Asia. Glioblastoma, also known as glioblastoma multiforme, is an...

Duration:00:43:59

TARDIS - A Simple Blood Draw to Determining a Patient’s Response to Neoadjuvant Therapy

11/23/2019
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor, Departments of Medical Oncology & Therapeutics Research and Population Sciences, Division of Clinical Cancer Genomics at City of Hope Comprehensive Cancer Center in Duarte, California. Hofland talks with...

Duration:00:47:56

How does Checkpoint Inhibitor Therapy Work when there’s no Checkpoint Expressed on a Patient's Cancer

8/3/2019
Today in The Onco’Zine Brief Peter Hofland talks with Dr. Michael Caligiuri, President of City of Hope National Medical Center in Los Angeles, California and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, and Dr. Jianhua Yu, professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, and a Scholar of The Leukemia & Lymphoma Society. By combining leading-edge science with true compassion and personalized treatment for each and every...

Duration:00:49:18

See More